The Effectiveness and Cost-effectiveness of Motion Style Acupuncture Treatment (MSAT) for Acute Neck Pain: A Multi-center Randomized Controlled Trial

November 18, 2021 updated by: In-Hyuk Ha, KMD, Jaseng Medical Foundation
The investigators will evaluate the comparative effectiveness and safety of Motion Style Acupuncture Treatment (MSAT) therapy for acute neck pain compared to acupuncture.

Study Overview

Detailed Description

This is a multi-center, randomized, controlled, comparative effectiveness clinical trial for acute neck pain. Motion style acupuncture requires a part of the patient's body to move passively or actively while acupuncture needles are retained.

Study Type

Interventional

Enrollment (Actual)

128

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Busan, Korea, Republic of
        • Haeundae Jaseng Hospital of Korean Medicine
      • Daejeon, Korea, Republic of, 35262
        • Daejeon Jaseng Hospital of Korean Medicine
    • Gangnam-Gu
      • Seoul, Gangnam-Gu, Korea, Republic of, 135-896
        • Jaseng Hospital of Korean Medicine
    • Gyeonggi Province
      • Bucheon, Gyeonggi Province, Korea, Republic of, 14598
        • Bucheon Jaseng Hospital of Korean Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 70 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Neck pain onset or worsen within one month
  • VAS of neck pain on movement or at rest of 5 or higher
  • Age between 19 and 70 years old
  • Participants who wrote a informed consent

Exclusion Criteria:

  • Participants who diagnosed with the serious disease that can cause pain (e.g. Migration of cancer reaching to spine, fracture of spine, dislocation of spine)
  • Progressive neurologic deficits or severe neurologic deficits
  • Participants who diagnosed with a soft tissue disease that can cause pain (Cancer, fibromyalgia, RA, or goat)
  • Chronic disease (e.g. Cardiovascular disease, kidney disease, dementia, diabetic neuropathy, or epilepsy)
  • Participants taking steroids, immunosuppressants, or psychotropic medication
  • Participants who could be inadequate or unsafe at acupuncture (e.g. Hemorrhagic disease, severe diabetes or taking anticoagulant drug)
  • Participants who took NSAIDs or acupuncture within 3 days
  • Participants who had undergone cervical surgery within 3 months
  • Participants who had a traffic accident within a month
  • Pregnant or women who planned to conceive
  • Participants who had participated in other clinical trial within 1 month, or have plan for participation in other trial within 6 months from enrollment
  • Participants who can not write informed consent
  • Participants who is difficult to participate in the trial according to investigator's decision

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Motion Style Acupuncture treatment
Motion Style Acupuncture treatment (2-3 times/week, 2 weeks)
MSAT required a part of the patient's body to move passively or actively while acupuncture needles are retained.
ACTIVE_COMPARATOR: Acupuncture treatment
Acupuncture treatment (2-3 times/week, 2 weeks)
General acupuncture

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analogue Scale(VAS) on movement
Time Frame: Change from baseline VAS at 3 weeks
Minimum 0, Maximum 100. Higher values represent a worse outcome
Change from baseline VAS at 3 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analogue Scale (VAS) on movement
Time Frame: Baseline(Week 1), Week 2, 3, 8
Minimum 0, Maximum 100. Higher values represent a worse outcome
Baseline(Week 1), Week 2, 3, 8
Visual Analogue Scale (VAS) at rest
Time Frame: Baseline(Week 1), Week 2, 3, 8
Minimum 0, Maximum 100. Higher values represent a worse outcome
Baseline(Week 1), Week 2, 3, 8
Numeric Rating Scale (NRS) on movement
Time Frame: Baseline(Week 1), Week 2, 3, 8
Minimum 0, Maximum 10. Higher values represent a worse outcome
Baseline(Week 1), Week 2, 3, 8
Numeric Rating Scale (NRS) at rest
Time Frame: Baseline(Week 1), Week 2, 3, 8
Minimum 0, Maximum 10. Higher values represent a worse outcome
Baseline(Week 1), Week 2, 3, 8
Vernon-Mior Neck Disability Index (NDI)
Time Frame: Baseline(Week 1), Week 2, 3, 8
Functional disability questionnaire
Baseline(Week 1), Week 2, 3, 8
Northwick Park Neck Pain Questionnaire (NPQ)
Time Frame: Baseline(Week 1), Week 2, 3, 8
Functional disability questionnaire and Pain questionnaire
Baseline(Week 1), Week 2, 3, 8
Patient Global Impression of Change (PGIC)
Time Frame: Week 3, 8
Global, patient-reported outcome, Minimum 1, Maximum 7, Higher values represent a better outcome
Week 3, 8
Range of movement (ROM) of flexion
Time Frame: Baseline(Week 1), Week 2, 3, 8
Range of movement of flexion
Baseline(Week 1), Week 2, 3, 8
Range of movement (ROM) of extension
Time Frame: Baseline(Week 1), Week 2, 3, 8
Range of movement of extension
Baseline(Week 1), Week 2, 3, 8
Range of movement (ROM) of Rt rotation
Time Frame: Baseline(Week 1), Week 2, 3, 8
Range of movement of Right rotation
Baseline(Week 1), Week 2, 3, 8
Range of movement (ROM) of Lt rotation
Time Frame: Baseline(Week 1), Week 2, 3, 8
Range of movement of Left rotation
Baseline(Week 1), Week 2, 3, 8
Range of movement (ROM) of Lt lateroflexion
Time Frame: Baseline(Week 1), Week 2, 3, 8
Range of movement of Left lateroflexion
Baseline(Week 1), Week 2, 3, 8
Range of movement (ROM) of Rt lateroflexion
Time Frame: Baseline(Week 1), Week 2, 3, 8
Range of movement of Right lateroflexion
Baseline(Week 1), Week 2, 3, 8
EQ-5D-5L
Time Frame: Baseline(Week 1), 3, 8
Health-related quality of life questionnaire
Baseline(Week 1), 3, 8
12-item Short-Form Health Survey (SF-12)
Time Frame: Baseline(Week 1), 3, 8
Health-related quality of life questionnaire
Baseline(Week 1), 3, 8
EuroQol Visual Analogue Scale (EQ-VAS)
Time Frame: Baseline(Week 1), 3, 8
Health-related quality of life questionnaire
Baseline(Week 1), 3, 8
Adverse events
Time Frame: Time Frame: Baseline (Week 1), Week 2, 3, 8 (every visit)
Safety outcome
Time Frame: Baseline (Week 1), Week 2, 3, 8 (every visit)
Drug Consumption
Time Frame: Time Frame: Baseline (Week 1), Week 2, 3, 8 (every visit)
Drug type and dose of prescribe for medicine or rescue medicine, and type and frequency of other treatments
Time Frame: Baseline (Week 1), Week 2, 3, 8 (every visit)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: In-Hyuk Ha, Dr., Jaseng Medical Foundation

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 10, 2020

Primary Completion (ACTUAL)

November 18, 2021

Study Completion (ACTUAL)

November 18, 2021

Study Registration Dates

First Submitted

August 26, 2020

First Submitted That Met QC Criteria

August 31, 2020

First Posted (ACTUAL)

September 4, 2020

Study Record Updates

Last Update Posted (ACTUAL)

November 19, 2021

Last Update Submitted That Met QC Criteria

November 18, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • JS-CT-2020-08

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Neck Pain

Clinical Trials on Motion Style Acupuncture Treatment (MSAT)

3
Subscribe